全球大流行期间股骨近端骨折患者的死亡率:西班牙HIP-COVID观察性研究的初步结果
该多中心回顾性描述性研究纳入西班牙13家医院在2020年3月14日至4月4日期间≥65岁、诊断股骨近端骨折且随访至少10天的136例患者,总死亡率为9.6%;COVID-19检测阳性的23例患者死亡率为30.4%,非手术治疗12例中8例(67%)死亡,手术治疗124例中5例(4%)死亡。
要点
- 股骨近端骨折患者总死亡率为9.6%(136例中13例死亡)。
- COVID-19检测阳性患者死亡率为30.4%(23例中7例死亡)。
- 非手术治疗患者死亡率为67%(12例中8例死亡),手术治疗为4%(124例中5例死亡)。
核心结论
- 合并COVID-19检测阳性的髋部骨折患者死亡率更高。
研究设计与样本
- 多中心、观察性、回顾性、描述性研究,收集西班牙13家主要医院的数据。
- 研究期间为西班牙政府宣布全国警戒状态(2020年3月14日)至研究期结束(2020年4月4日)。
- 纳入标准为年龄≥65岁、期间因股骨近端骨折就诊于参与医院急诊科、且最低随访10天。
- 共纳入136例髋部骨折患者,其中124例接受手术治疗,12例接受非手术治疗。
主要发现
- 总死亡率为9.6%。
- 62例患者接受了COVID-19检测,其中23例阳性。
- 23例COVID-19阳性患者平均随访14天时死亡率为30.4%(23例中7例死亡)。
- 检测阴性患者死亡率为10.3%(39例中4例死亡),未检测患者死亡率为2.7%(74例中2例死亡)。
- 非手术治疗12例中8例(67%)死亡,手术治疗124例中5例(4%)死亡;各中心结果存在差异。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The outbreak of coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2), in December 2019 in Wuhan, People's Republic of China, has developed into an unprecedented pandemic with enormous pressure on health-care providers around the world. A higher mortality rate has been described in older infected individuals. Patients with hip fracture are a particularly vulnerable population during this pandemic because older age is associated with a higher mortality rate. Our aim was to describe the early mortality rate and demographic variables in a hip fracture sample population in Spain during the coronavirus pandemic. METHODS: This is a multicenter, observational, retrospective, descriptive study. We collected data from 13 major hospitals in Spain from the beginning of the national state of alarm (declared on March 14, 2020, by the Spanish government) until the end of our study period on April 4, 2020. All patients who were ≥65 years of age, presented to the Emergency Department of the participating hospitals during this period with a diagnosis of proximal femoral fracture, and had a minimum follow-up of 10 days were included in the cohort. In addition to mortality, demographic and other potential prognostic variables were also collected. RESULTS: In this study, 136 patients with a hip fracture were included. Of these patients, 124 underwent a surgical procedure and 12 were managed nonoperatively. The total mortality rate was 9.6%. Sixty-two patients were tested for COVID-19, with 23 patients being positive. The mortality rate for these 23 patients was 30.4% (7 of 23 patients) at a mean follow-up of 14 days. The mortality rate was 10.3% (4 of 39) for patients who had been tested and had a negative result and 2.7% (2 of 74) for patients who had not been tested. Of the 12 patients who were managed nonoperatively, 8 (67%) died, whereas, of the 124 patients who were surgically treated, 5 (4%) died. Results differed among centers. CONCLUSIONS: There is a higher mortality rate in patients with a hip fracture and an associated positive test for COVID-19. LEVEL OF EVIDENCE: Prognostic Level IV. See Instructions for Authors for a complete description of levels of evidence.
引用
- Muñoz Vives JM, Jornet-Gibert M, Cámara-Cabrera J, et al. Mortality Rates of Patients with Proximal Femoral Fracture in a Worldwide Pandemic: Preliminary Results of the Spanish HIP-COVID Observational Study. J Bone Joint Surg Am. 2020. PMID: 32618917. doi:10.2106/JBJS.20.00686
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。